| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.0063 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |